Diabetes Management Success Rate is a critical performance indicator that reflects the effectiveness of diabetes care programs.
It directly influences patient outcomes, operational efficiency, and overall financial health of healthcare organizations.
A higher success rate indicates better patient adherence to treatment plans, leading to reduced complications and lower healthcare costs.
Conversely, low rates may signal gaps in care delivery or patient engagement.
Organizations that leverage this KPI can optimize resource allocation and improve strategic alignment with health objectives.
Tracking this metric enables data-driven decision-making and enhances management reporting capabilities.
Diabetes Management Success Rate sits in KPI Depot's Health and Wellness KPI group, a sixty-nine metric collection built around workforce health and the cost that follows from it. Its balanced scorecard placement is the internal perspective, which is the right home for it: the rate describes how well a care or wellness program runs, not what employees feel about it and not what finance books at the end of the year. At priority twenty-five it is a supporting metric in that KPI group rather than a headline one. The lead metrics ahead of it are Absenteeism Rate, Turnover Rate, and Employee Burnout Rate, and the KPI group treats those as the fast-moving workforce signals. This one moves slowly, because the underlying clinical result it depends on is refreshed only as often as patients are tested.
The metrics it is most closely tied to sit just above it. Employee Health Improvement Rate and Chronic Disease Management Effectiveness cover the same ground at a wider grain, and that overlap is worth naming rather than glossing over. Chronic Disease Management Effectiveness pools several conditions into one figure, so a diabetes-specific success rate is the drill-down that tells you whether the pooled number moved because of diabetes work or in spite of it. If the two disagree, the pooled metric is usually the one hiding something. Further down the KPI group, Healthcare Cost Per Employee and Healthcare Cost Savings occupy the financial perspective and act as the lagging confirmation that anything here mattered financially.
The genuine tension in this KPI group is with Healthcare Cost Per Employee. Improving this rate normally means more contact: more testing, more medication adherence work, more visits, more specialist referrals. All of that lands in the cost metric first and shows up as a success rate improvement later, if it shows up at all within the reporting year. A program judged on cost per employee in the same period it is judged on this rate will be judged twice for the same activity, once favorably and once not. There is a second tension that is easy to miss. Case-finding work, the kind that Employee Health Improvement Rate rewards, adds newly identified patients to this metric's denominator, and newly identified patients are the least likely to be at the control threshold the measure specification defines. Find more people and this rate falls even though the program did the right thing. Read the two together or the better program will look like the worse one.
The measure specification is the metric. That sounds like a technicality and it is not. Once a customer picks a steward's specification, almost every argument about this rate has already been settled: who is in the denominator, which laboratory result counts, how long the look-back runs, who is excluded, and where the control threshold the measure specification defines sits. Two organizations that use different specifications will report different rates on identical patients and both will be correct. So the first deliverable of any program measuring this is a written statement of which specification is in force and in which version. Change it later and you have broken your own trend line, which should be said out loud when it happens rather than discovered by a board member.
The denominator decides the story. There are several defensible choices and they do not agree with each other:
The single largest lever on the reported rate is not any of the care work. It is how the program handles patients with no laboratory result in the look-back window. Count them as not controlled and the rate reflects both clinical results and test capture. Exclude them and the rate reflects only the patients who were tested, which flatters a program with poor engagement. Most published specifications take the first route, and customers moving from an internally invented metric to a published one are often shocked by the drop. Nothing got worse. The missing-result rule changed. Related: when a patient has several results in the window, the specification names which one counts, usually the most recent, and a registry that averages results instead will not reconcile with it.
Exclusions carry more weight than they appear to. Age bands, hospice enrollment, advanced illness, frailty, and certain comorbidities commonly remove patients from the denominator, and the population removed is not random. A program serving an older or sicker population will see its denominator shrink more than a peer's, which changes the rate on its own. Type one and type two patients are frequently pooled into a single figure even though the management pathway, the staffing, and the achievable result differ. If the volume supports it, hold them apart internally even when the external report pools them.
Where the data comes from changes what you can see. Claims-derived measurement knows that a test was ordered and paid for but often not what the result was, so it can support a testing rate and struggle with a control rate. Registry-derived measurement has results but only for the patients someone remembered to enroll, and registries decay quietly. Electronic health record derived measurement has the richest data and the narrowest window, since it sees only what happened inside the organizations feeding it. The recurring failure across all three is laboratory result capture from outside labs: a result drawn at a retail clinic, a hospital, or a lab the organization has no interface with either arrives as unstructured text or does not arrive at all, and the patient is then scored as untested. Before blaming clinical performance for a low rate, audit a sample of denominator patients scored as having no result and find out how many actually have one somewhere.
Panel churn deserves its own check. Patients who leave the plan or the practice mid-period are handled differently by different specifications, and a program with high turnover can post a rate that describes a population that no longer exists. Run the rate once on the specification's denominator and once on patients present for the whole period. A wide gap means the reported figure is being driven by membership movement rather than by care.
Two more things distort comparisons. Risk adjustment is applied inconsistently to this metric, and social risk factors including transportation, food access, medication cost, and housing stability affect achievable results substantially; an unadjusted comparison between two panels with different social risk profiles is a comparison of the panels, not of the programs. And many reporting frameworks bundle glycemic control with blood pressure control, lipid management, and eye or foot screening into one composite success rate. A composite can move because screening completion rose while glycemic results were flat, so always report the components alongside the bundle or the number tells you nothing about what to do next. Finally, any survey-based source rests on self-reported status and self-reported results, which is a different evidentiary standard from a verified laboratory value, and the two should never be placed in the same column of the same table.
Many organizations overlook the nuances of patient engagement, which can significantly distort the Diabetes Management Success Rate.
Enhancing the Diabetes Management Success Rate requires a multifaceted approach focused on patient engagement and care delivery improvements.
We have 2 relevant benchmarks in our benchmarks database.
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | average | adults with diabetes | United States |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | average | 2017–2018 | U.S. adults with diagnosed diabetes | United States |
Browse the Top Benchmarked KPIs in Health and Wellness
Both benchmark sources tracked here are United States population surveillance rather than program reporting, and that distinction does most of the work. MMWR reports on adults with diagnosed diabetes, so anyone whose diabetes has not been identified is outside the denominator entirely. Preventing Chronic Disease frames its population as adults with diabetes, a broader framing that does not resolve to the same base. Neither is describing an employer panel, a health plan membership, or an attributed provider panel, which is what a customer measuring this internally almost always has.
Before treating any external figure as comparable, verify a short list. First, which measure specification produced it and where the control threshold the measure specification defines sits, since a different steward or a different threshold makes two rates non-comparable no matter how similar they look. Second, whether the denominator is a surveyed population, a diagnosed population, or an enrolled and attributed panel, and whether patients with no laboratory result in the look-back window were counted as not controlled or removed from the denominator. Third, the vintage and the survey method, because a national estimate built from self-report and periodic examination cycles is not built the same way as a rate computed from claims or from a clinical record, and the years it covers may predate any change you are trying to measure against. A source that does not let you answer all three is not a benchmark for your program; it is context.
The Health and Wellness KPI group's OKR set includes the objective Optimize healthcare investments to reduce cost without compromising employee care quality, and that is where this metric belongs as a key result. The group's own examples pair cost movement with Chronic Disease Management Effectiveness and Health Risk Assessment Completion Rate, on the logic that you cannot manage what you have not identified. Diabetes Management Success Rate is the condition-specific key result under that objective, and the honest way to write it is directional and paired: improve the rate while holding or improving test capture, so the improvement cannot be produced by a shrinking denominator. Pair it with Healthcare Cost Per Employee as the group's OKR material does, and expect the two to move out of phase across the first few quarters.
A second framing comes from the group's objective to Create a resilient workforce by reducing absenteeism and enhancing mental wellness. Here the metric is a supporting key result rather than the headline one. The group's lead metrics for that objective are Absenteeism Rate and Employee Burnout Rate; a diabetes management rate contributes to the same outcome through a slower path, and setting it as a primary key result on a quarterly cycle will disappoint a team for reasons that have nothing to do with their work. The group's best-practice guidance to tie Health Risk Assessment completion to targeted intervention applies directly: treat identification as the near-term key result and this rate as the annual one it eventually feeds.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
Key factors include patient adherence to treatment plans, the effectiveness of healthcare provider communication, and the availability of support resources. Additionally, socioeconomic factors can also play a significant role in patient outcomes.
Technology can facilitate better tracking of patient data, provide reminders for medication, and enhance communication between patients and healthcare providers. Mobile apps and telehealth options can significantly increase patient engagement and adherence.
Patient education is crucial for improving self-management skills and understanding treatment plans. Well-informed patients are more likely to adhere to their prescribed regimens, leading to better health outcomes.
Regular evaluations, ideally quarterly, allow organizations to track progress and identify areas needing improvement. Frequent assessments enable timely adjustments to care strategies.
Yes, community programs that provide resources and support can significantly enhance patient engagement and education. These initiatives often lead to improved adherence and better health outcomes.
An ideal target for the Diabetes Management Success Rate should be above 80%. Achieving this threshold indicates effective management and strong patient adherence to treatment plans.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)